Gerhard Domagk

Gerhard Johannes Paul Domagk (30 October 1895 – 24 April 1964) was a German pathologist and bacteriologist renowned for discovering the antibacterial effects of prontosil, the first sulfonamide compound demonstrated to combat systemic bacterial infections effectively in vivo. This breakthrough, achieved through systematic testing of azo dyes at I.G. Farbenindustrie's research laboratory in Wuppertal-Elberfeld, established the foundation for chemotherapeutic treatment of diseases like streptococcal sepsis, previously almost invariably fatal.

Born in Lagow in the Brandenburg Marches, Domagk studied medicine at the University of Kiel, graduating in 1921 after interruptions for World War I service, during which he was wounded in 1914 and later worked in sanitary units combating epidemics such as cholera in Russia. He advanced in pathology, serving as a university lecturer in pathological anatomy at Greifswald in 1924 and Münster in 1925, before joining I.G. Farbenindustrie in 1927 as director of the pathological and bacteriological department, where his focus on chemotherapy against infectious diseases, tuberculosis, and carcinoma led to the 1932 observation that prontosil rubrum protected mice from otherwise lethal streptococcal injections—results confirmed in human cases, including his own daughter's severe arm infection from a sewing needle prick. Domagk's findings, published in 1935, spurred rapid clinical adoption and the synthesis of related sulfonamides, though prontosil itself required metabolic activation to sulfanilamide for activity.